Evidence map›Paper›PMID 35935125›Full record

ArticleJournal of interventional cardiology2022

Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy.

Julia Anna Lurz, Eileen Schmidt, Karl-Patrik Kresoja, Federica Torri, Sebastian König, Angeliki Darma, Arash Arya, Livio Bertagnolli, Gerhard Hindricks, Borislav Dinov

Open access · goldAbstract read
In one paragraph

Article in Journal of interventional cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Julia Anna LurzDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.ORCID https://orcid.org/0000-0002-3099-8196
Eileen SchmidtDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.
Karl-Patrik KresojaDepartment of Cardiology, Herzzentrum Leipzig at University, Leipzig, Germany.ORCID https://orcid.org/0000-0002-8616-6751
Federica TorriDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.
Sebastian KönigDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.ORCID https://orcid.org/0000-0002-3759-3052
Angeliki DarmaDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.ORCID https://orcid.org/0000-0003-4756-2775
Arash AryaDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.
Livio BertagnolliDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.
Gerhard HindricksDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.
Borislav DinovDepartment of Electrophysiology, Herzzentrum Leipzig at University, Leipzig, Germany.ORCID https://orcid.org/0000-0003-1104-8491
Deutsches Herzzentrum der Charité · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Catheter ablation of ventricular tachycardia (VT) in patients with ischemic cardiomyopathy (ICM) is an effective tool to prevent VT recurrences. Chronic total occlusion (CTO) represents a clinically relevant entity in ICM patients and is an independent predictor of ventricular arrhythmia and mortality. The effects of CTO on the outcome of VT ablation are not well-studied. Objective: This analysis aimed to identify the impact of CTO, revascularized, or not revascularized, on the outcome of VT ablation. Methods and Results: Of 385 consecutive subjects with ICM-VT who underwent catheter VT ablation for monomorphic VT at Heart Center Leipzig between 2008 and 2017, 108 patients without CTO and 191 patients with CTO were included in the analysis. Within a median follow-up time of 557 days (IQR 149, 1095), VT recurred in 77 (40%) patients in the CTO and 40 (37.0%) in the non-CTO cohort ( Conclusion: In ICM patients with and without CTO, VT ablation was associated with equal effectiveness with regard to VT recurrence. However, in revascularized CTO patients, the risk of recurrence of VT after ablation was significantly increased.

Indexed as

CardiomyopathiesCatheter AblationMyocardial IschemiaTachycardia, VentricularHumansRecurrenceTreatment Outcome

Identifiers

PMID35935125
PMCPMC9314168
OpenAlexW4285803280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.